24 March 2015
PHT CORPORATION SPEEDS CLINICAL TRIAL TIMES WITH VODAFONE GLOBAL M2M TECHNOLOGY
Vodafone’s Machine-to-Machine (M2M) technology enables PHT Corporation to more efficiently manage worldwide clinical trials through real-time access to patient experience data
Vodafone and PHT Corporation, the leading provider of technologies used to collect electronic data for clinical research from patients, are working together to connect the PHT electronic clinical outcome assessment (eCOA) system to Vodafone’s global M2M network. Using Vodafone’s global M2M network, PHT provides pharmaceutical trial sponsors real-time access to patient data enabling them to collect higher quality data and make faster research decisions with confidence. Currently the PHT eCOA System is used to collect data in hundreds of clinical trials in more than 75 countries.